Bronchogen vs Vitamin D3 Injection
A side-by-side research comparison of Bronchogen and Vitamin D3 Injection across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Bronchogen | Vitamin D3 Injection |
|---|---|---|
| Full name | Bronchogen (Ala-Asp-Glu-Leu Bronchopulmonary Bioregulator) | Cholecalciferol (Vitamin D3) Injectable |
| Category | Immune Support | Immune Support |
| Status | Research compound (peptide bioregulator) | Compounded supplement |
| Mechanism | As a signal peptide (Ala-Asp-Glu-Leu), it is proposed to regulate gene expression in respiratory epithelial tissue, supporting airway lining integrity, antioxidant defense, and local respiratory immune function. | Converts to 25-hydroxyvitamin D then to active 1,25-dihydroxyvitamin D. Modulates over 200 genes including those for immune function, calcium absorption, bone remodeling, and hormone production. |
| Molecular weight | ~445 Da | 384.64 Da |
| Half-life | Short (peptide) | ~15 days (storage form) |
| Bioavailability | Oral (encapsulated) or subcutaneous | ~100% IM |
| Typical dose | ~1-2 capsules/day or short injectable courses | 50,000-100,000 IU |
| Frequency | Once daily | Weekly to monthly |
| Route | Oral capsule or subcutaneous | Intramuscular injection |
Bronchogen reported benefits
- Respiratory/airway support
- Bronchopulmonary tissue maintenance (proposed)
- Local respiratory immune support
- Short course-based protocol
Vitamin D3 Injection reported benefits
- Rapid deficiency correction
- Immune system optimization
- Bone health
- Hormone support
- Mood improvement
- Reduced inflammation
Related comparisons
Research and educational reference only. Not medical advice.